MedPath

RE-PB HYOS ELIXIR

Belladonna/Phenobarbital

Approved
Approval ID

4de8df82-23db-421b-8531-c755854b3e5e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 26, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

BELLADONNA ALKALOIDS W/ PHENOBARBITAL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-594
Product Classification
G
Generic Name
BELLADONNA ALKALOIDS W/ PHENOBARBITAL
Product Specifications
Route of AdministrationORAL
Effective DateOctober 20, 2009
FDA Product Classification

INGREDIENTS (11)

ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TY
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
PHENOBARBITALActive
Quantity: 16.2 mg in 5 mL
Code: YQE403BP4D
Classification: ACTIB
ATROPINE SULFATEActive
Quantity: 0.0194 mg in 5 mL
Code: 03J5ZE7KA5
Classification: ACTIB
SCOPOLAMINE HYDROBROMIDEActive
Quantity: 0.0065 mg in 5 mL
Code: 451IFR0GXB
Classification: ACTIB
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
HYOSCYAMINE SULFATEActive
Quantity: 0.1037 mg in 5 mL
Code: F2R8V82B84
Classification: ACTIB

Drug Labeling Information

CLINICAL STUDIES SECTION

LOINC: 34092-7Updated: 10/20/2009

CLINICAL PHARMACOLOGY

This drug combination provides peripheral anticholinergic/antispasmodic action and mild sedation.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RE-PB HYOS ELIXIR - FDA Drug Approval Details